Cart
sales@molnova.com
Neurokinin A(4-10)(TFA)
CAS No. 97559-35-8
Neurokinin A(4-10)(TFA) ( —— )
Catalog No. M21023 CAS No. 97559-35-8
Neurokinin A(4-10)(TFA) is an agonist of tachykinin NK2 receptor .
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 231 | Get Quote |
|
| 10MG | 407 | Get Quote |
|
| 25MG | 810 | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameNeurokinin A(4-10)(TFA)
-
NoteResearch use only not for human use.
-
Brief DescriptionNeurokinin A(4-10)(TFA) is an agonist of tachykinin NK2 receptor .
-
DescriptionNeurokinin A(4-10)(TFA) is an agonist of tachykinin NK2 receptor .
-
Synonyms——
-
PathwayGPCR/G Protein
-
TargetNeurokinin Receptor
-
RecptorNK2?
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number97559-35-8
-
Formula Weight766.91
-
Molecular FormulaC34H54N8O10S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCSCCC(NC(=O)C(CC(C)C)NC(=O)CNC(=O)C(NC(=O)C(Cc1ccccc1)NC(=O)C(CO)NC(=O)C(N)CC(=O)O)C(C)C)C(N)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Warner FJ Miller RC Burcher Eet al.Structure-activity relationship of neurokinin A(4-10) at the human tachykinin NK(2) receptor: the effect of amino acid substitutions on receptor affinity and function.Biochem Pharmacol. 2002 Jun 15 ;63(12):2181-6.
molnova catalog
related products
-
[Sar9] Substance P
[Sar9]-Substance P is one of NK-1 receptor agonist. The action of SP on progesterone metabolism was mimicked by the rNK1-specific agonist [Sar-9,Met(O2)11]-SP.
-
Eledoisin Related Pe...
Eledoisin Related Peptide is a tachykinin receptor ligand and analogue of substance P. ERP can increase spontaneous activity and depolarizing neurons by decreasing membrane conductance.
-
Fosaprepitant dimegl...
Fosaprepitant dimeglumine(MK-0517) is a neurokinin-1 receptor antagonist for the prevention of chemotherapy-induced nausea and vomiting.
